CN100512840C - Chinese medicine for treating hypertension, diabetes and coronary heart disease caused by atherosclerosis - Google Patents
Chinese medicine for treating hypertension, diabetes and coronary heart disease caused by atherosclerosis Download PDFInfo
- Publication number
- CN100512840C CN100512840C CNB2005100105767A CN200510010576A CN100512840C CN 100512840 C CN100512840 C CN 100512840C CN B2005100105767 A CNB2005100105767 A CN B2005100105767A CN 200510010576 A CN200510010576 A CN 200510010576A CN 100512840 C CN100512840 C CN 100512840C
- Authority
- CN
- China
- Prior art keywords
- radix
- diabetes
- heart disease
- coronary heart
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicament for treating hypertension, diabetes and coronary disease, which is prepared from constituents of (by weight ratio) baikal skullcap root 20-35%, elephantopus 5-10%, Chinese angelica root 10-18%, root of herbaceous peony 9-18%, calcium sulphate 10-15% through steps of disintegrating, mixing and synthesizing honeyed pills with bee honey.
Description
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of hypertension, diabetes and coronary heart disease.
Background technology
Hypertension, diabetes and coronary heart disease are the diseases that a kind of utmost point refractory is healed, and morbific reason is more complicated also.At present, for also not having a kind of specific drug by the caused hypertension of atherosclerosis, diabetes and coronary heart disease, though some medicine is effective in cure, toxic and side effects is also bigger.
Summary of the invention
The purpose of this invention is to provide the Chinese medicine of hypertension, diabetes and coronary heart disease that a kind of treatment causes by atherosclerosis, it can effect a radical cure in the short period of time by the caused hypertension of atherosclerosis, diabetes and coronary heart disease.It comprises following component in percentage by weight: Radix Scutellariae 20～35%, Radix Gentianae 5～10%, Radix Angelicae Sinensis 10～18%, the Radix Paeoniae Alba 9～18% and Gypsum Fibrosum 10～15%, the content sum of this each composition of Chinese medicine equals 100%.With standby after Radix Scutellariae, Radix Gentianae, Radix Angelicae Sinensis, the Radix Paeoniae Alba and Gypsum Fibrosum pulverizing, the mixing with the synthetic honeyed pill of Mel.Earlier pugil Folium Camelliae sinensis is chewed before taking and swallowed, and then take honeyed pill.Radix Scutellariae has activating blood circulation to dissipate blood stasis, blood vessel dilating, removing heat from blood, hemostasis and blood pressure reduction effect, can treat the headache that hypertension causes; Radix Gentianae has the effect of activating blood circulation to dissipate blood stasis, blood vessel dilating, heat clearing and damp drying, eliminating pathogen in the liver gallbladder fire, can treat the liver-fire headache, and the effect that brings high blood pressure down is arranged; Radix Angelicae Sinensis can obviously be expanded and penetrating blood vessel, remove rubbish in the blood, have enrich blood, invigorate blood circulation, the analgesic effect, have the headache of cold coagulation, chest pain and the costalgia that blood stasis causes concurrently with its treatment stasis in the traditional medicine, modern times are treated coronary heart disease, angina pectoris, thromboangiitis obliterans with it, can anti-platelet aggregation and antithrombotic form, resist myocardial ischemia, anoxia, blood vessel dilating, improve blood circulation and blood fat reducing effect; The Radix Paeoniae Alba can suppress platelet aggregation, dissolve thrombosis, has the effect of nourishing blood for regulating menstruation, flat pain relieving, blood vessel dilating, enhancing myocardial nutrition blood flow; The effect that Folium Camelliae sinensis has effective expansion and penetrating blood vessel, dissolving blood fat and brings high blood pressure down; The heat clearing away of Gypsum Fibrosum energy, pathogenic fire purging, removing heat from blood can alleviate thirsty that diabetes cause.Medicine of the present invention effects a radical cure hypertension, diabetes and coronary heart disease by removing atherosclerosis, has the advantage that curative effect is fast, have no side effect, and has higher promotional value.
The specific embodiment
The specific embodiment one: present embodiment comprises following component in percentage by weight: Radix Scutellariae 20～35%, Radix Gentianae 5～10%, Radix Angelicae Sinensis 10～18%, the Radix Paeoniae Alba 9～18% and Gypsum Fibrosum 10～15%.Following table 1, table 2 and table 3 is respectively the middle pharmacodynamics laboratory report of present embodiment treatment hypertension, diabetes and coronary heart disease.
Usage and dosage: service once before sleeping in last hour of breakfast and evening, each 15 gram honeyed pill, clothes are corresponding to about 12% Folium Camelliae sinensis of honeyed pill weight earlier, and Folium Camelliae sinensis is chewed and is swallowed back clothes pill, and eliminating cold for resuscitation water send down.If taking the hyperpietic of hypertension pill, when taking this medicine, should continue to take hypertension pill, after medicine of the present invention must be taken one month, then according to feeling, if dizzy, feeling of fullness in the head disappears substantially, then the hypertension pill of just taking is divided to subtract (being to subtract 1/10 amount every day) in ten days.
Use medicine of the present invention that 30 routine hyperpietics are treated, obvious effective rate 30% (9/30) effective percentage 63.33% (19/30 people), no change 6.66% (2/30), its total effective rate 93.33%, medicine of the present invention is as shown in table 1 to the therapeutic effect of hypertension, and the blood pressure values unit in the table is KPa.
Table 1
Use medicine of the present invention that 35 routine diabeticss are treated, total effective rate 85.68% (30 people), cure rate 31.4% (11 people) wherein, inefficiency 14.28% (5 people), medicine of the present invention is as shown in table 2 to the treatment of diabetes effect.Blood sugar concentration 3.89-6.11 mMs/liter between be normal value, blood sugar concentration is determined through hospital's urine examination."+" expression blood sugar concentration in the table 2 is higher than normal value.
Table 2
Use medicine of the present invention that 29 routine patients with coronary heart disease are treated, total effective rate 84.50%, wherein cure rate 29.48%, and invalid 13.79%.Medicine of the present invention is as shown in table 3 to the therapeutic effect of coronary heart disease.(as the improvement of coronary heart disease and cure and to have an electro-cardiogram according to subjective symptoms and check) above observes case history through hospital's check of having an electro-cardiogram.The conscious pain symptom of " ++ " in the table 3 expression patient is very serious, and "+" expression patient is conscious pain symptom, the no pain symptom of "-" expression.
Table 3
The specific embodiment two: the difference of present embodiment and embodiment one is the composition that it also comprises by weight percentage Rhizoma Chuanxiong 0.5%, the Radix Angelicae Dahuricae 0.5%, Radix Bupleuri 2～3%, Flos Chrysanthemi 1～2%.Rhizoma Chuanxiong has the effect of the QI invigorating of invigorating blood circulation, and is used for the treatment of the blood stasis stagnation of QI, can invigorate blood circulation and can circulation of qi promoting." book on Chinese herbal medicine converges and says " middle record Rhizoma Chuanxiong can suppress vascular smooth muscle and shrink, coronary artery dilator, increase coronary flow, improve the myocardial ischemia situation, can reduce myocardial oxygen consumption, increase brain and LBF amount, reduce peripheral vascular resistance, can reduce the platelet surface vigor, anticoagulant, can prevent thrombosis, and hypotensive effect is arranged; The Radix Angelicae Dahuricae has the diffusing wind that induces sweat, sensible, pain relieving, and the treatment head rises and has a headache; Radix Bupleuri have evacuate bring down a fever, the effect of dispersing the stagnated live-QI to relieve the stagnation of QI, can reduce the cholesterol in the blood.Flos Chrysanthemi has that dispelling wind and heat pathogens, suppressing the hyperactive liver make eye bright, the effect of heat-clearing and toxic substances removing, can coronary artery dilator, and coronary blood flow increasing improves myocardial oxygen consumption, and obvious hypotensive effect is arranged.
The specific embodiment three: the difference of present embodiment and embodiment one is the composition that it also comprises by weight percentage Radix Glycyrrhizae 0.3～0.5%, the Radix Rehmanniae 0.6～0.8%, Herba Menthae 0.3～0.5%.Herba Menthae has dispelling wind and heat pathogens, the clear sharp head's effect, can treat headache, conjunctival congestion, energy stimulating central nervous system, expansion blood capillary; The Radix Rehmanniae has the effect of the removing heat from blood that purifies the blood, and can treat heat symptom-complex and obnubilation and wake up, and the energy blood sugar lowering promotes solidifying of blood.Radix Glycyrrhizae can be in harmonious proportion the property of medicine.
Claims (3)
1, treats the Chinese medicine of the hypertension, diabetes and the coronary heart disease that cause by atherosclerosis, it is characterized in that it comprises following component in percentage by weight: Radix Scutellariae 20～35%, Radix Gentianae 5～10%, Radix Angelicae Sinensis 10～18%, the Radix Paeoniae Alba 9～18% and Gypsum Fibrosum 10～15%, the content sum of this each composition of Chinese medicine equals 100%.
2, the Chinese medicine of the hypertension, diabetes and the coronary heart disease that are caused by atherosclerosis of treatment according to claim 1 is characterized in that it also comprises the composition of by weight percentage Rhizoma Chuanxiong 0.5%, the Radix Angelicae Dahuricae 0.5%, Radix Bupleuri 2～3%, Flos Chrysanthemi 1～2%.
3, the Chinese medicine of the hypertension, diabetes and the coronary heart disease that cause by atherosclerosis of treatment according to claim 1; It is characterized in that it also comprises the composition of by weight percentage Radix Glycyrrhizae 0.3～0.5%, the Radix Rehmanniae 0.6～0.8%, Herba Menthae 0.3～0.5%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100105767A CN100512840C (en) | 2005-11-25 | 2005-11-25 | Chinese medicine for treating hypertension, diabetes and coronary heart disease caused by atherosclerosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100105767A CN100512840C (en) | 2005-11-25 | 2005-11-25 | Chinese medicine for treating hypertension, diabetes and coronary heart disease caused by atherosclerosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1970040A CN1970040A (en) | 2007-05-30 |
| CN100512840C true CN100512840C (en) | 2009-07-15 |
Family
ID=38111188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100105767A Expired - Fee Related CN100512840C (en) | 2005-11-25 | 2005-11-25 | Chinese medicine for treating hypertension, diabetes and coronary heart disease caused by atherosclerosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100512840C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104857386A (en) * | 2015-05-13 | 2015-08-26 | 柳州市耕青科技有限公司 | Traditional Chinese medicine formula for treating arteriosclerosis-induced diseases |
| CN104857385A (en) * | 2015-05-13 | 2015-08-26 | 柳州市耕青科技有限公司 | Traditional Chinese medicine formula for treating cardiovascular and cerebrovascular diseases |
| CN104940747A (en) * | 2015-06-08 | 2015-09-30 | 柳州市宝杨种植专业合作社 | Novel traditional Chinese medicine formula for preventing and treating cardiovascular and cerebrovascular diseases |
| CN104922555A (en) * | 2015-06-08 | 2015-09-23 | 柳州市宝杨种植专业合作社 | Formula of traditional Chinese medicine containing dendrobium officinale for effectively preventing and treating diseases caused by arteriosclerosis |
-
2005
- 2005-11-25 CN CNB2005100105767A patent/CN100512840C/en not_active Expired - Fee Related
Non-Patent Citations (4)
| Title |
|---|
| 中药抗动脉粥样硬化作用的研究进展. 檀战山等.中国中医急症，第12卷第1期. 2003 |
| 中药抗动脉粥样硬化作用的研究进展. 檀战山等.中国中医急症，第12卷第1期. 2003 * |
| 抗动脉粥样硬化中药的研究进展. 张保亭.中国中西医结合杂志，第23卷第5期. 2003 |
| 抗动脉粥样硬化中药的研究进展. 张保亭.中国中西医结合杂志，第23卷第5期. 2003 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1970040A (en) | 2007-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101972373B (en) | Chinese medicinal preparation for treating hypertension, hyperglycemia and hyperlipidemia | |
| CN101254272B (en) | Medicament for promoting coronary circulation and embolism resistance | |
| CN101496887B (en) | Medicament for treating acute hot, itching and wet severe type and chronic urticaria | |
| CN100512840C (en) | Chinese medicine for treating hypertension, diabetes and coronary heart disease caused by atherosclerosis | |
| CN102727860A (en) | Medicament for treating intestinal adhesion and bowel obstruction after abdominal operation and preparation method thereof | |
| CN103520366A (en) | Traditional Chinese medicine for treating spastic hemiplegia after stroke | |
| CN101269157B (en) | Method for preparing wine for warming meridian, removing paralysism, releasing tendon, activating collaterals to relieve pain | |
| CN102247552A (en) | Kudzuvine root and cinnamomvine capsules for cardiovascular and cerebrovascular diseases | |
| CN102652805A (en) | Medicine for treating rabies | |
| CN1124856C (en) | Pill for treating hemiplegia | |
| CN102430105A (en) | Traditional Chinese medicine composite for treating chronic gastritis | |
| CN103083575B (en) | Medicine for treating hypertension | |
| CN102451340A (en) | Traditional Chinese medicine foot bath prescription for treating gout | |
| CN102145143B (en) | Pharmaceutical composition for treatment of gastritis and preparation method of pharmaceutical composition | |
| CN102940820A (en) | Traditional Chinese medicine composition for treating diarrhea | |
| CN102935185A (en) | Pills for treating neurasthenia and preparation method | |
| CN102349957A (en) | Traditional Chinese medicine composition for treating prurigo | |
| CN101461851A (en) | Chinese herbal medicine for treating hyperosteogeny | |
| CN103893675A (en) | Traditional Chinese medicinal preparation for treating epigastric pain | |
| CN102988776A (en) | Traditional Chinese medicine composition for treating vertigo | |
| CN103212039A (en) | Traditional Chinese medicine composition for treating infantile cough caused by qi deficiency | |
| CN102961696A (en) | Chinese medicinal composition for treating diabetic nephropathy edema | |
| CN101961459B (en) | Oral medicament for treating hemiplegia | |
| CN103028058B (en) | Traditional Chinese medicine composition for treating feebleness | |
| CN101912547B (en) | Medicament for treating dizziness and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090715 Termination date: 20121125 |